Affymetrix' GeneTitan(TM) System Delivers Automatic Answers and Sets New Standard in Genomic Analysis

Affymetrix Inc. (NASDAQ:AFFX) today announces the GeneTitan(TM) System, the only complete platform to automate customer workflow from target preparation through array processing and data analysis, which maximizes data reproducibility, user productivity and throughput scalability. The first application, whole-genome expression profiling, benefits from the new, flexible 24- and 96-array plate format with whole-genome content on a single array and the new HT 3’ IVT Express Assay, which uses a streamlined protocol and less starting material.

Source: Affymetrix